Navigation Links
Two Regenstrief investigators receive NIH career development awards
Date:6/12/2014

INDIANAPOLIS -- Two Regenstrief Institute investigators and Indiana University Center for Aging Research scientists -- Michael LaMantia, M.D., MPH, and Noll L. Campbell, PharmD -- have each received five-year Mentored Patient-Oriented Research Career Development K23 Awards from the National Institute on Aging at the National Institutes of Health.

Dr. LaMantia is an assistant professor of medicine at the IU School of Medicine. His K23 award supports a project titled "DEEDS: Delirium Evaluation in the Emergency Department for Seniors."

Delirium affects approximately 10 percent of older adults who seek care in the emergency department, yet it is unrecognized in the majority of cases. To improve the care and management of older adults with delirium, it is critical to understand the dynamics that affect delirium recognition by emergency service providers. The goal of Dr. LaMantia's research is to determine the factors that influence delirium recognition and to discern those approaches to delirium assessment that are most associated with its identification. Dr. LaMantia reviewed the problem in a study published earlier this year in the Annals of Emergency Medicine.

Dr. Campbell is a research assistant professor in the Purdue University College of Pharmacy and a clinical pharmacy specialist in geriatrics with Eskenazi Health. His K23 career development award supports a project titled "Evaluating the Adverse Cognitive Effects of Medications."

This work continues his research into the role common medications play on cognition in older adults. A 2013 study by Dr. Campbell found that using anticholinergics -- which block the neurotransmitter acetylcholine -- for as few as 60 days causes memory problems in older adults. This award will further investigate the impact anticholinergics have on cognition and will also study the impact of statins and antihistamines.


'/>"/>
Contact: Cindy Fox Aisen
caisen@iupui.edu
317-843-2276
Indiana University
Source:Eurekalert  

Page: 1

Related medicine news :

1. IU, Regenstrief study: New noninvasive colorectal cancer screening tool highly accurate
2. Regenstrief, IU study: Half of hospitalized adults over 65 need surrogate decision-makers
3. Regenstrief and IU review finds lack of delirium screening in the emergency department
4. RSNA and Regenstrief Institute launch effort to unify radiology procedure naming
5. CHICA, automated system developed by Regenstrief and IU, improves autism screening rate
6. Regenstrief and IU study: Older adults with severe mental illness challenge healthcare system
7. IU, Regenstrief initiative aims to decrease hospitalization of nursing home residents
8. Regenstrief and IU study investigates older adults views on cancer screening
9. Regenstrief study: Informatics tools underutilized in prevention of hospital-acquired infection
10. Regenstrief investigator inducted into medical informatics honor society
11. Regenstrief study finds that generic drugs often have incorrect safety labeling
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Two Regenstrief investigators receive NIH career development awards
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: